Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 89, Issue 3, Pages 170-185Publisher
WILEY
DOI: 10.1002/jso.20178
Keywords
pancreatic endocrine tumor; non-functioning; MEN1; VHL; therapy
Ask authors/readers for more resources
Pancreatic endocrine tumors (PETs) are rare neoplasms oriainating from the amine precursor uptake and decarboxylation (APUD) stein cells. Although the majority of PETs are sporadic, they frequently occur in familial syndromes. PETs may cause a variety of functional syndromes or symptoms of local progression if they are nonfunctional. General neuroendocrine tumor markers are highly sensitive in the diaonostic assessment of a PET. Imaging studies for tumor localization and staging include computer tomography (CT) scan, magnetic resonance imaging (MRI), In-111-octreotide scan, MIBG, and endoscopic ultrasonography (EUS). Treatment of PETs often requires a multi-modality approach; however, surgical resection remains the only curative therapy for localized (non-metastatic) disease. Treatment of metastatic disease includes biologic agents, cytotoxic chemotherapy, and liver-directed therapies. (C) 2005 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available